Methods, Enzymes, and Engineered Strains to Synthesize Beta-Hydroxy L-Alpha Amino Acids in Metabolically Active Bacterial Cells
Technology
As evidenced by recent scientific publications, conference talks, academic collaborations, and our conversations with scientists at large pharmaceutical companies, a strategic priority for the pharmaceutical industry is the ability to synthesize a broader array of non-standard amino acids (nsAAs) efficiently and selectively. Another priority in the industry is to adopt biocatalysts for one-pot synthesis of small molecules.University of Delaware researchers have discovered new biocatalysts to catalyze the formation of nsAAs. These building blocks can be used to manufacture therapeutic compounds including proteins, peptides, antibiotics, and a brand-name FDA-approved small molecule drug. Our enzymes generate a broad range of beta hydroxylated nsAAs with better performance characteristics than those known in the literature.
Benefits
- Catalyze the formation of many new nsAAs, including those that have handles for chemical conjugation
- Catalyze existing nsAA products more efficiently
- Elimination of multiple protection/deprotection steps required for chemical synthesis
- Extremely high diastereomeric ratio
- Opportunity to couple multiple enzyme-catalyzed steps in one pot
Applications
- Small molecule and peptide process chemistry
- Biotechnology